Upgrade to SI Premium - Free Trial

PNGAF (PNGAF)

0.33 -0.01 (2.94%)

Chart
Today 6M 1Y 5Y

Latest Headlines

The Precision Peptide Company Inc. Announces Extension of Investor Relations Agreement with Emerging Markets Consulting, LLC June 5, 2026 7:32 AM - StreetInsider Precision Peptide signs US compounding pharmacy agreement June 2, 2026 7:02 AM - StreetInsider The Precision Peptide Company Inc. Signs Agreement with U.S.-Based 503A Sterile Compounding Pharmacy - Peptides to be 100% Compounded in the United States June 2, 2026 7:02 AM - StreetInsider The Precision Peptide Company to Exhibit as the Only Peptide Company at Dave Asprey's BEYOND Conference in Austin, Texas May 28, 2026 7:32 AM - StreetInsider The Precision Peptide Company Inc. Places Order for 20,000 BPC-157 Transdermal Patches May 26, 2026 7:32 AM - StreetInsider The Precision Peptide Company (BPC) Expands on Exclusive 50/50 Revenue Share Peptide Partnership with MMA.INC (MMA) May 21, 2026 7:32 AM - StreetInsider Precision Peptide's BPC-157 patch achieves 95.5% purity in lab tests May 19, 2026 7:02 AM - StreetInsider The Precision Peptide Company (BPC) Lead Product Achieves 95.5% Purity in Independent Lab Testing, Clearing the Industry Benchmark and Advancing Toward Commercial Launch May 19, 2026 7:02 AM - StreetInsider The Precision Peptide Company's Chief Scientific Officer Justin Kirkland to Be Featured on The Human Upgrade with Dave Asprey May 14, 2026 7:34 AM - StreetInsider MMA.INC partners with Precision Peptide in 50/50 revenue share deal May 12, 2026 8:31 AM - StreetInsider MMA.INC (NYSE American: MMA) Enters Exclusive 50/50 Revenue Share Peptide Partnership with Precision Peptide (CSE: BPC) May 12, 2026 8:30 AM - Globe NewsWire The Precision Peptide Company Inc. Announces Exclusive Strategic Marketing Partnership with Mixed Martial Arts Group Limited May 12, 2026 7:31 AM - StreetInsider Precision Peptide nears launch of needle-free BPC-157 patch May 7, 2026 7:35 AM - StreetInsider The Precision Peptide Company Nears Commercial Launch of Needle-Free BPC-157 Patch as Final Testing Advances May 7, 2026 7:35 AM - StreetInsider C$1.3 Million in Proceeds Received by The Precision Peptide Company from Warrant Exercises May 5, 2026 7:31 AM - StreetInsider The Precision Peptide Company Grants RSUs and Stock Options and Settles Debt May 4, 2026 7:35 AM - StreetInsider The Precision Peptide Company Announces Strategic Product Marketing Agreement April 23, 2026 8:02 AM - StreetInsider The Precision Peptide Company Applauds FDA Action Advancing Regulatory Clarity for Peptide Therapies April 16, 2026 7:34 AM - StreetInsider The Precision Peptide Company Announces Public Relations and Consulting Services Agreement April 15, 2026 8:06 AM - StreetInsider Full Article List